Category: Research/Reports

Trump-Aligned Think Tank Proposes Lowering U.S. Drug Prices Through IRA and Other Policies, Doesn’t Weigh In on 340B Program

March 27, 2025 Shannon Young, Associate Editor/Senior Writer Views

America First Policy Institute released a March 21 brief detailing how policymakers “could accelerate drug development and enhance patient health by implementing reforms that discourage other countries from freeloading off American drug innovation.”

A conservative think tank, which officials who served in President Donald Trump’s (R) first administration founded to advance his priorities, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Misinformation Makes Up Small Part of 340B Conversations Online, But Garners Outsized Attention, Analysis Finds

March 11, 2025 Shannon Young, Associate Editor/Senior Writer Views

Storyful Rx analyzed more than 6,000 social media posts and articles mentioning the 340B program between Aug. 11, 2024 and Feb. 11, 2025.

Although misinformation accounts for just 2% of the overall 340B conversations taking place online, “conspiratorial narratives” driven by conservative influencers—and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drug Industry-Funded Study Finds 340B Contract Pharmacy Bills Costly to Employer Health Plans and States; Critics Slam Its Methodology and Funding Source

February 21, 2025 Shannon Young, Associate Editor/Senior Writer Views

IQVIA examined how state 340B contract pharmacy access bills could affect state and local governments in a Feb. 4 white paper funded by the National Pharmaceutical Council.

340B contract pharmacy access bills could cost states millions and employer health plans more, according to a new study funded [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Study Finds 340B Providers Prescribe More Often Without Increasing Survival Rate of Breast Cancer; Hospital Advocate Challenges Conclusion

February 13, 2025 Bella Czajkowski, National Correspondent Views

The Feb. 3 study compared 340B versus non-340B provider prescribing patterns for breast cancer patients.

A recent study suggested that 340B providers prescribe more drugs for treating breast cancer, but do not have any significant [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Program Had No Impact on Prostate Cancer Care, Study Suggests

January 16, 2025 Bella Czajkowski, National Correspondent Views

A study in the academic journal Cancer Medicine examined the relationship between the 340B program and prostate cancer care.

Participation in the 340B program did not increase the number of vulnerable patients beginning targeted care for prostate cancer, a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Minnesota Issues 1st State Report on 340B, Critics Say it ‘Misses Critical Context’

November 26, 2024 Shannon Young, Associate Editor/Senior Writer Views

The Minnesota Department of Health on Monday unveiled the findings of its first legislatively required 340B Covered Entity Report.

Minnesota providers, namely the state’s largest 340B hospitals, generated hundreds of millions of dollars in collective net revenue from the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Panelists at Healthcare Purchaser Conference Link 340B to Higher Employer Healthcare Costs, Hospital Consolidation

November 21, 2024 William Newton, Associate Editor/Senior Writer Views

Bret Jackson, president and CEO of the Michigan Economic Alliance, moderated a Nov. 19 panel with U.S. Rep. Victoria Spartz (R-Ind.), Thomas Johnson, executive director of ASAP 340B, and Ge Bai, Ph.D., professor of accounting and health policy at Johns Hopkins University.

The 340B program is increasing healthcare costs for employers and driving hospital consolidation, argued panelists at a recent healthcare purchaser [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

FQHCs Reinvest 340B Savings in Safety-Net Care, JAMA Study Finds

October 10, 2024 Bella Czajkowski, National Correspondent Views

Federally qualified health centers (FQHCs) appear to use their 340B program savings to enhance safety-net care, according to a new study in JAMA Health Forum.

Federally qualified health centers (FQHCs) appear to use their 340B program savings to enhance safety-net care, according to a new [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

ACA Played Key Role in 340B Growth, Drug Industry Consulting Firm Finds

September 12, 2024 Bella Czajkowski, National Correspondent Views

An IQVIA analysis looked at the 340B program’s growth under the Affordable Care Act.

The 340B program has outgrown patient demands and requires additional restrictions and oversight, according to a new report from a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Analysis Finds Growing Private Equity, Corporate Investments in 340B; Firm Conducting Study Fails to Mention Its Own PE Funding

August 29, 2024 Shannon Young, Associate Editor/Senior Writer Views

A new Berkeley Research Group issue brief looked at trends in 340B investments.

The 340B program’s growth in recent decades has helped it attract a growing number of corporate and private equity investments, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live